Document is current
Any future updates will be listed below
-
Authors
Russo, Elisa
Cappadona, Francesca
Macciò, Lucia
Di Vincenzo, Julie
Piaggio, Michela
Verzola, Daniela
Chirco, Giuseppe
Garibotto, Giacomo
Esposito, Pasquale
Viazzi, Francesca https://orcid.org/0000-0003-4219-7043
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05998837 at ClinicalTrials.govDocuments that mention this clinical trial
Dapagliflozin Reduces Ambulatory Arterial Stiffness Index in CKD Patients with and Without Diabetes Independently of Blood Pressure Control: Results from the GLUcose Transport and Renal PROtection in Chronic Kidney Disease (GLUTREPRO) Trial
https://doi.org/10.1007/s40292-025-00764-3
-
Funding
Funding for this research was provided by:
Università degli Studi di Genova
- License Information
-
More Information
Article History
Received: 8 September 2025
Accepted: 30 October 2025
First Online: 9 December 2025
Declarations
:
: Authors are required to disclose any possible conflicts of interest. All forms of support and financial involvement (e.g. employment, consultancies, honoraria, stock ownership and options, expert testimony, grants or patents received or pending, royalties) which took place in the previous three years should be listed, regardless of their potential relevance to the paper. Also the nonfinancial relationships (personal, political, or professional) that may potentially influence the writing of the manuscript should be declared. If there is no conflict of interest, please state: “The authors have no conflicts of interest to declare.”
: This study was approved by the local institutional review committee (the Ethic Committee of the Ligurian Region CE 150193 with the ID D169AL00005) and authorized by the Italian Drug Agency (AIFA). The study was registered in the EU Clinical Trials Register (EudraCT: 2020-004835-26) and online at the (Unique identifier: NCT05998837, 13th April 2021).
: This study was conducted in accordance with the GCP/ICH E6 Guidelines and the principles of the Declaration of Helsinki and all patients provided written informed consent.
